In these studies, we tested the potential role of the α7 nicotinic acetylcholine receptor (α7 nAChR) in a rodent model of acid-induced acute lung injury. We first determined that the α7 nAChR was expressed by alveolar macrophages and lung epithelial cells. Then, using an acid-induced acute lung injury mouse model, we found that nicotine, choline, and PNU-282987 (a specific α7 nAChR agonist) decreased excess lung water and lung vascular permeability, and reduced protein concentration in the bronchoalveolar lavage (BAL). Deficiency of α7 nAChR resulted in a 2-fold increase in excess lung water and lung vascular permeability. The reduction of proinflammatory cytokines (MIP-2 and TNF-α) in the BAL with nicotine probably resulted from the suppression of NF-κB activation in alveolar macrophages. The beneficial effect of nicotine was also tested in rat model of acid-induced acute lung injury in which BAL protein and RAGE, a marker of type I cell injury, were reduced by nicotine treatment. These results indicate that activation of α7 nAChR may provide a new therapeutic pathway for the treatment of acute lung injury. 
INTRODUCTION
There is new evidence that neural mechanisms can downregulate inflammation in vivo by decreasing the release of TNF-α by endotoxin-stimulated macrophages (1) . This anti-inflammatory pathway is mediated by an interaction between acetylcholine, the principal neurotransmitter of the vagus nerve, and cholinergic nicotinic acetylcholine receptors on macrophages (2) . Nicotine pretreatment decreases inflammatory cell influx, proinflammatory cytokine levels, and liver injury in septic peritonitis (3) . Stimulation of α7 nicotinic acetylcholine receptor (α7 nAChR) prevents activation of the NF-κB pathway and thereby improves survival in experimental models of sepsis (4, 5) .
The overall aim of these experimental studies was to test the hypothesis that activation of the α7 nAChR mediated cholinergic anti-inflammatory pathway could reduce the severity of acid aspiration induced acute lung injury by attenuating proinflammatory responses. The first objective was to determine whether alveolar macrophages, activated neutrophils, and (lung) epithelial cells expressed α7 nAChR. The secondary objective was to determine whether activation of the α7 nAChR by administration of the cholinergic agonist (nicotine, choline, and PNU-282987) would protect acid-induced acute lung injury. The third objective was to test whether knockout of α7 nAChR would worsen acid-induced acute lung injury in mice. jugular vein. Mice were monitored for 4 h and sacrificed to measure excess lung water and lung vascular permeability or to carry out bronchoalveolar lavage.
Acid-induced acute lung injury in a ventilated rat model. A ventilated rat model was used to compare with the experimental setting in our prior studies (7) . Rats were placed supine, and a tracheotomy tube (15-gauge luer stub adapter, Becton Dickinson, Sparks, MD) was inserted. The rats were treated with either saline or nicotine (3.5 mg/kg, ip) 5~10 min before intratracheal instillation with pH 1.0 hydrochloric acid (3 ml/kg), and then ventilated with a tidal volume of 7 ml/kg, a rate of 60 times/min, and 5 cmH 2 O PEEP. Two hours later, rats were euthanized and the lungs were lavaged with 3 ml cold PBS. We then measured protein concentration and soluble RAGE (a marker of alveolar type I cell injury) levels in the BAL.
Excess lung water (ELW) and lung extravascular plasma equivalent (EPE).
As previously described (8) , the lungs were removed, counted in a γ-counter (Packard, Meriden, CT), weighed, and homogenized (after addition of 1 ml distilled water). The blood was collected through right ventricle puncture. The homogenate was weighed and a fraction was centrifuged (12, 000 rpm, 8 min) for assay of hemoglobin concentration in the supernatant. Another fraction of homogenate, supernatant and blood were weighed and then desiccated in an oven (60°C for 24 h). We used the following formula to calculate ELW: 1) Measurement of the water fraction separately in the lung homogenate (WF H ), the supernatant of the homogenate (WF S ), and the blood (WF B ) by:
where W wet is the wet weight and W dry is the dry weight.
2) Calculation of blood volume in the lung:
where 1.039 is the density of blood, Q H is the weight of lung homogenate (whole lung wet weight + weight of the distilled water), WF H is the water fraction of lung homogenate, Hb S is the hemoglobin concentration of supernatant of lung homogenate, WF S is the water fraction in supernatant of lung homogenate, and Hb B is the hemoglobin concentration of blood.
3) Calculation of water volume in the lung
where W w is the weight of the distilled water added when the lung is homogenized. 
Where Q W exp equals water volume of the lung in the experimental group; Q d exp equals dry weight of the lung in the experimental group. The controls were the normal mice with the same age as the experimental group.
Lung extravascular plasma equivalents (EPE) (index of lung vascular permeability to protein) were calculated as the counts of 125 I-albumin in the blood free lung tissue divided by the counts of 125 I-albumin in the plasma.
Bronchoalveolar lavage, protein levels, and leukocyte count. We used the methods as previously described (8 RAGE levels in the BAL were measured as previously described (7).
Histology.
After euthanasia by inhalation of halothane, the chest and abdomen were rapidly opened and the base of the heart was clamped to prevent escape of the pulmonary blood volume. The thoracic organs were removed en bloc, and 10% formalin was instilled through the trachea at a pressure of 25 cmH 2 O. After 72 h fixation, lungs were embedded in paraffin, and 5-µm sections were cut and stained with hematoxylin and eosin, as in our prior studies (8) . (9) . Briefly, AT II cells were isolated from cadaveric human lungs that were declined by the Northern California Transplant Donor Network. As described in our prior studies (10, 11) , these lungs are in relatively normal physiological conditions. Using cytospin, alveolar macrophages, neutrophils, and alveolar type II cells were prepared on slides and fixed in Statistical Analysis. Statistics were done by SPSS software (SPSS Inc., Chicago, IL).
Detection of
An unpaired t-test was used unless there were multiple comparisons in which case we used ANOVA with post hoc Bonferoni test (significance level set at p < 0.05). The results are shown as mean ± SD.
RESULTS
Expression of α7 nAChR. In the normal mouse lung, α7 nAChR immunoreactivity was present in the bronchial epithelia ( Figure 1A -B). Because we could not isolate a sufficiently pure population of mouse type II cells, we studied human alveolar epithelial type II cells and found that there was strong α7 nAChR immunoreactivity in these human alveolar type II cells ( Figure 1C-D) . In the normal mouse alveolar macrophage, intense α7 nAChR immunoreactivity was present on the membrane and cytoplasm ( Figure 1E -F). To study α7 nAChR immunoreactivity in alveolar proinflammatory cells, mice were intratracheally instilled with either saline or acid, and the lungs were lavaged 4 h later.
The proinflammatory cells in the airspaces of the lung were collected by performing bronchoalveolar lavage. In the injured lung, intense α7 nAChR immunoreactivity was found on alveolar neutrophils adjacent to alveolar macrophages ( Figure 1G-H) . The intensity of α7 nAChR immunostaining in proinflammatory cells in the injured lung was 3-fold increased compared to the control ( Figure 1I ).
Nicotine attenuated acid-induced acute lung injury in mice and rats.
To test whether activation of α7 nAChR would reduce excess lung water and lung vascular permeability in acid-induced acute lung injury, we divided mice into four groups: (i) saline + saline group: the mice were pretreated with saline and then IT saline; (ii) nicotine + saline group: the mice were treated with nicotine (3.5 mg/kg, iv) 5~10 min before IT saline; (iii) saline + acid group: the mice were pretreated with saline and then IT acid; (iv) nicotine + acid group, the mice were pretreated with nicotine and then IT acid. Four hours later, blood was withdrawn and the lungs were removed to measure excess lung water and lung vascular permeability. Excess lung water and extravascular plasma equivalents in the saline + acid group was 5~6 fold increased compared to the saline + saline group. Excess lung water and extravascular plasma equivalents in the nicotine + acid group were reduced by 60% compared to the saline + acid group (Figure 2A-B) .
Histologically, there was less pulmonary edema and neutrophil infiltration in the nicotine + acid mice compared to the saline + acid mice (Figure 2C-D) . We also tested the effect of nicotine in acid-induced acute lung injury in rats to verify that the effect of nicotine was not just specific to mice. Also, we tested whether nicotine would affect the release of RAGE, a type I epithelial cell injury marker in the rat acid-induced acute lung injury.
Nicotine reduced the BAL protein concentration (a measure of lung vascular permeability) and the levels of RAGE in the BAL compared to the saline therapy (Figure
2E-F).
To determine whether the protective effect of nicotine on acid-induced acute lung injury is α7 nAChR dependent, mice were separately treated with saline, nicotine Nicotine reduced protein, neutrophil differentiation, and cytokine levels in the BAL in mice and prevented activation of NF-κB in mouse alveolar macrophages. To determine whether activation of α7 nAChR would affect the protein concentration, neutrophil counts, and cytokine levels in the BAL in acid-induced acute lung injury, mice were divided into three groups: (i) saline + saline group: the mice were pretreated with saline and then IT saline; (ii) saline + acid group: the mice were pretreated with saline and then IT acid; (iii) nicotine + acid group, the mice were pretreated with nicotine (3.5 mg/kg, iv) 5~10 min before IT acid. After 4 hours, nicotine reduced acid-induced increase in the protein concentration, leukocyte counts, and the number of neutrophils in the BAL compared to saline (Figure 3A-C) . Nicotine also reduced MIP-2 and TNF-α levels in the BAL compared to saline (Figure 3D-E) .
To study whether activation of α7 nAChR would alter activation of NF-κB p65 in acid-induced acute lung injury, mice were divided into three groups: (i) the saline + saline group, the mice were pretreated with saline, and then IT saline; (ii) the saline + acid group, the mice were pretreated with saline, and then IT acid; (iii) the nicotine + acid group, the mice were pretreated with nicotine (3.5 mg/kg, iv) 5~10 min before IT acid. 
Choline attenuated acid-induced acute lung injury in mice.
To test whether activation of α7 nAChR by choline (EC 50 of 1.6 mM, a full α7 nAChR agonist) (13) would alter the course of acid-induced acute lung injury, mice were pretreated with saline or choline (60 mg/kg, iv) 5~10 min ahead of intratracheal instillation of acid or saline.
Mice were killed 4 h later, and the lungs were harvested or lavaged with PBS.
Intratracheal instillation of acid increased excess lung water and extravascular plasma equivalents. Administration of choline decreased excess lung water and extravascular plasma equivalents by 2-fold compared to the saline treated group (Figure 4A--B) .
Neutrophil accumulation in the airspaces was increased 4 h after intratracheal challenge with acid, while injection of choline decreased the neutrophil differentiation in BAL compared to the saline treated group (Figure 4D-E) .
PNU-282987 attenuated acid-induced acute lung injury in mice.
To confirm whether activation of α7 nAChR would reduce acid-induced acute lung injury, PNU-282987 (a highly specific α7 nAChR agonist, K i of 27 nM) (14) was given (2.4 mg/kg, ip) 20 min before acid instillation. The control group received the same volume of saline. After 4 h, PNU-282987 reduced excess lung water and extravascular plasma equivalents compared to saline (Figure 5A-B) . PNU-282987 also decreased neutrophil count and protein level in the BAL (Figure 5C-D) . PNU-282987 reduced TNF-α and MIP-2 levels in the BAL (Figure 5E-F) .
Knockout of α7 nAChR reduced acid-induced acute lung injury in mice.
To test whether α7 nAChR deficiency would worsen acid-induced acute lung injury, wildtype (n = 5) and α7 nAChR deficient mice (n = 4) were intratracheally challenged with acid. One mouse in the α7 nAChR deficient group died at 2 h and the lung was grossly edematous.
The other 3 α7 nAChR knockout mice manifested more severe respiratory distress compared to the wildtype. No death occurred in the wildtype group. Four hours later, the excess lung water and lung vascular permeability in the α7 nAChR deficient mice increased 2-fold compared to the wildtype (Figure 6 A-B) .
DISCUSSION
Acute lung injury in association with gastric aspiration carries a mortality of up to 30% (15) . NF-κB plays a key role in the molecular and cellular events in acid-induced acute lung injury (16) . Depletion of alveolar macrophages results in decreased production of inflammatory mediators in acid aspiration (23-80%) (15) . In addition, the neutrophil is an important mediator of acid-induced acute lung injury (17) . Thus, with an animal model of acid-induced lung injury, it is possible to test the hypothesis that activation of α7 nAChR may regulate pulmonary edema and proinflammatory responses in acid-induced acute lung injury.
The importance of the cholinergic anti-inflammatory pathway has recently been recognized (1, 2). Acetylcholine released by efferent vagus nerves inhibits macrophage activation (18) . α7 nAChR is required for acetylcholine inhibition of macrophage TNF release (2). Nicotine, as the prototype agonist of nAChR, can protect mice from lethal sepsis (4) by inhibiting HMGB1 production. A selective α7 nAChR agonist (2.4-dimethoxybenzylidene anabaseine dihydrochloride, GTS-21) has been used to attenuate experimental pancreatitis (19) . In this study, to the best of our knowledge, we first demonstrated that activation of α7 nAChR with its agonists (nicotine, choline, and PNU- In addition to human bronchial cells, the endothelial cells express α7 nAChR (21).
It is possible that activation of α7 nAChR in the endothelial cells reduces neutrophil adhesion and infiltration. As expected, neutrophils were the main cell population in the airspaces of the lung 4 h after acid instillation. Administration of nicotine, choline, and PNU-282987 reduced neutrophil accumulation in the airspaces. This result can be explained by reduction of MIP-2 and neutrophil chemotaxis. Another explanation is that activation of α7 nAChR in the endothelial cells may reduce endothelial cell activation and leukocyte binding (22) .
In the endotoxemia mouse model, activation of α7 nAChR by vagus nerve stimulation reduced the levels of TNF-α in the plasma, liver, and spleen, but not in the lung (23, 24) .
There may be several reasons to explain why their findings were different from ours: (i)
The endotoxemia model is different from our acid-induced acute lung injury model; (ii)
The TNF-α was measured only in the lung homogenate. Thus, we cannot rule out that there was a difference in the TNF-α level in the BAL because alveolar macrophages are the major sources of TNF-α; (iii) LPS was given by intravenous injection rather than intratracheal instillation. Even with intratracheal instillation of LPS, 12-24 hours are required to develop peak pulmonary edema and inflammation. Thus, we believe that the lungs were probably not injured sufficiently at 90 and 180 min after intravenous injection of LPS to demonstrate the beneficial effect of vagus nerve stimulation.
Taken together, activation of α7 nAChR can inhibit NF-κB activation in alveolar macrophages and reduces the production of proinflammatory cytokines (MIP-2 and TNF-α). Thus, administration of α7 nAChR agonist can reduce neutrophil accumulation in the airspaces of the lung as well as decrease pulmonary edema and lung inflammation. These results suggest that activation of α7 nAChR may be useful as a novel anti-inflammatory therapy to treat acute lung injury. 
